Immunopathogenetic roles of leukotrienes in human diseases.
The recent definition of the pathways of generation and structures of diverse products of the lipoxygenation of arachidonic acid has established the identity of a new family of mediators of hypersensitivity and inflammation. Studies of the effects of these mediators have shown that leukotrienes C, D, and E, the constitutents of the slow-reacting substance of anaphylaxis (SRS-A), are extremely potent smooth muscle contractile and vasoactive factors. Leukotriene B is a highly active stimulus of neutrophil and eosinophil functions and suppresses the immunological capabilities of T lymphocytes. The development of specific and sensitive radioimmunoassays has permitted the detection of elevated concentrations of leukotrienes in tissues or exudates in several diseases, including asthma, diverse allergic states, adult respiratory distress syndrome, psoriasis, spondyloarthritis, and gout. The application of selective inhibitors and antagonists of leukotrienes will clarify their pathogenetic contributions in human diseases and may yield new therapeutic approaches.
D001091:Arachidonate Lipoxygenases; D001095:Arachidonic Acids / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D001168:Arthritis / Q000378:metabolism; D001249:Asthma / Q000378:metabolism; D003550:Cystic Fibrosis / Q000378:metabolism; D006801:Humans; D006967:Hypersensitivity / Q000378:metabolism; D017572:Leukotriene A4; D007975:Leukotriene B4 / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D017999:Leukotriene E4; D008084:Lipoxygenase / Q000378:metabolism; D011565:Psoriasis / Q000378:metabolism; D013189:SRS-A / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D013666:Tears / Q000032:analysis
D001095:Arachidonic Acids; D017572:Leukotriene A4; D013189:SRS-A; D007975:Leukotriene B4; D017999:Leukotriene E4; D001091:Arachidonate Lipoxygenases; D008084:Lipoxygenase